Aspen Grove Capital, LLC Bristol Myers Squibb CO Transaction History

Aspen Grove Capital, LLC

  • $425 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $44,788 - $49,730
-703 Reduced 8.89%
7,205 $461 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $2,234 - $2,534
34 Added 0.43%
7,908 $548 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $539,211 - $638,502
7,874 New
7,874 $567 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aspen Grove Capital, LLC Portfolio

Follow Aspen Grove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspen Grove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspen Grove Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email